Pamidronate (disodium)
Pamidronate disodium (CGP 23339A), the second-generation nitrogen-containing bisphosphonate, is an inhibitor of bone loss. Pamidronate disodium significantly inhibits subchondral bone loss in early osteoarthritis by upregulating the expression of osteoprotegerin in cartilage and subchondral bone, and inhibiting the expression of RANKL and MMP-9 in both tissues, as well as TLR-4 in cartilage, thereby alleviating cartilage degeneration. Additionally, Pamidronate disodium can inhibit the signaling of Wnt and β-catenin, and is applicable for research on osteoporosis and osteosarcoma[1][2][3][4].
Product Specifications
CAS Number
[57248-88-1]
Product Name Alternative
CGP 23339A
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
RANKL/RANK ; Toll-like Receptor (TLR) ; Wnt; β-catenin
Type
Reference compound
Related Pathways
Immunology/Inflammation; NF-κB; Stem Cell/Wnt
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pamidronate-disodium.html
Purity
98.0
Solubility
H2O : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OP(C(O)(P(O)(O[Na])=O)CCN)(O[Na])=O
Molecular Formula
C3H9NNa2O7P2
Molecular Weight
279.03
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items